Douglas A. Bakan

Dr. Douglas A. Bakan has served as our Executive Vice President of Technical Operations since May 2018. Previously, Dr. Bakan served as Senior Vice President of Technical Operations from January 2017 to May 2018. He has extensive expertise in all aspects of pharmaceutical drug development and commercialization along with over 25-years of experience in firms ranging in size from entrepreneurial startups to established publicly traded companies. In various roles at companies including Medicis Pharmaceuticals (now Valeant Pharmaceuticals), Novalar Pharmaceuticals, Neurocrine Biosciences, Alerion Biomedical, MetaProbe LLC, Corvas International and Molecular Biosystems, Inc., Dr. Bakan has been responsible for activities including discovery research, nonclinical and clinical testing, CMC efforts for drug substance and drug product supply, quality system development, program management, regulatory submission preparation and review, intellectual property creation and prosecution, venture capital financing, technology in-licensing and out-licensing, and technical due diligence. Most recently, Dr. Bakan has provided pharmaceutical consulting services to various clients in the areas of product development, regulatory dossier preparation and technical due diligence. Dr. Bakan has been an author on more than 50 scientific publications and is an inventor on more than 35 issued or pending patents. Dr. Bakan earned his BS in Biomedical Engineering at UC San Diego, his Ph.D. in Biology from UC San Diego and completed post-doctoral research at the University of Michigan in the laboratories of Drs. Raymond Counsell and Jamey Weichert.